Table 1

ED50 (milligram per kilogram) for stimulus and rate altering effects of morphine before, during, and after treatment with clocinnamox

Maximal S.D.ED501-a95% CLDose Ratio vs. Control1-b95% CLDose Ratio vs. 20 MS1-c95% CL
Stimulus effects
+ 10 C-Cam (n = 5)
  Control1000.990.52–1.9
  10 mg/kg C-Cam1006.41-150 2.6–166.52.7–15
 Chronic MS + 3.2 C-Cam (n = 7)
  Control1000.580.40–0.85
  20 mg/kg per day MS1001.41-150 0.84–2.32.41.6–3.5
  3.2 mg/kg C-Cam91101-150 1-151 4.1–25186.8–457.33.7–14
  Recovery, week 1952.31-150 0.97–5.54.01.8–8.81.70.93–2.9
  Recovery, week 2931.31-150 0.63–2.82.30.98–5.40.960.50–1.8
 Chronic MS + 10 C-Cam (n = 6)
  Control980.560.31–1.0
  20 mg/kg per day MS991.91-150 1.2–3.03.42.4–4.8
  10 mg/kg C-Cam86121-150 1-151 1-d 4.9–32229.0–546.52.9–15
  Recovery, week 1861.10.078–162.00.12–310.580.034–9.9
  Recovery, week 21000.680.31–1.51.20.50–2.90.360.14–0.95
Rate effects
+ 10 C-Cam
  Control2.81.3–6.2
  10 mg/kg C-Cam181-150 10–346.53.3–13
 Chronic MS + 3.2 C-Cam
  Control3.32.6–4.0
  20 mg/kg per day MS6.11-150 4.4–8.21.91.4–2.4
  3.2 mg/kg C-Cam351-150 1-151 24–52118.6–145.84.3–7.9
  Recovery, week 19.31-150 1-151 6.8–132.82.1–3.81.51.2–2.0
  Recovery, week 24.01-151 3.3–4.91.20.99–1.50.670.58–0.77
 Chronic MS + 10 C-Cam
  Control2.31.2–4.3
  20 mg/kg per day MS4.12.8–6.11.80.95–3.4
  10 mg/kg C-Cam771-150 1-151 41–1453417–65199.8–36
  Recovery, week 1201-150 1-151 12–368.94.4–185.02.8–8.6
  Recovery, week 24.53.0–6.61.91.2–3.11.10.67–1.8

Clocinnamox treatment was administered alone or during treatment with doses of 20 mg/kg per day morphine.

  • 1-150  Significantly different from control ED50,P < 0.05.

  • 1-151  Significantly different from ED50 during treatment with 20 mg/kg per day morphine, P < 0.05.

  • 1-a All non-linear regressions of stimulus effects or response rate on log10 dose were statistically significant,P < 0.05. Unless noted, slopes of test curves did not differ from slopes of control curves.

  • 1-b Ratio expressed as (ED50 after treatment / ED50 for control curve).

  • 1-c Ratio expressed as (ED50 after treatment / ED50 following MS treatment).

  • 1-d Slope differs from those of control curve and curve during treatment with 20 mg/kg per day morphine.